SpineGuard has signed a partnership with ISIR (Institute of Intelligent Systems and Robotics), a laboratory affiliated with Sorbonne University, CNRS (French National Centre for Scientific Research), and INSERM (French National Institute of Health and Medical Research), all specialized in surgical robotics. The goal is to scientifically demonstrate that a robot, combined with DSG technology, can automatically and repeatedly detect bone breaches during surgical drilling, thereby enabling the autonomous placement of bone implants by the robot itself.
This collaboration is already bearing fruit with:
- A first patent application filed in 2017 (now published) and a second one recently submitted
- The acceptance of a first scientific paper for presentation at the Hamlyn Symposium (June 2019, London), a conference that annually brings together the latest and most important developments in the field of surgical robotics. This preclinical feasibility study was awarded Best Scientific Paper during the symposium.
In addition, SpineGuard is collaborating on the European FAROS project (Functional Accurate Robotic Surgery).
The FAROS project began on January 1st, 2021, for a duration of three years and has received funding from Horizon 2020, the European Union’s largest research and innovation program, with nearly €80 billion in funding over seven years. Four prestigious universities are participating in the project: Université Catholique de Louvain, Sorbonne University, King’s College London, and the University of Zurich. SpineGuard is a project partner, along with the Balgrist University Hospital in Zurich.
SpineGuard’s contribution to this ambitious project is to provide, through DSG®, a key technology for feedback to the orthopedic surgical robot, enabling it to access a wide range of detection capabilities in order to autonomously and precisely carry out complex surgical tasks. DSG technology is expected to play a central role in ensuring both safety and accuracy.
In addition, two SpineGuard members serve on the project’s Advisory Committee: Maurice Bourlion, a member of SpineGuard’s Board of Directors and Scientific Committee, and Thibault Chandanson, R&D Director. Jimmy Da Silva, a SpineGuard doctoral engineer under a CIFRE contract with the Institute of Intelligent Systems and Robotics (ISIR) at Sorbonne University, is also part of the research team. Pre-clinical testing stage.
About SpineGuard
Pierre Jérôme and Stéphane Bette founded SpineGuard in January 2009 with the goal of delivering the clinical benefits of the DSG™ (Dynamic Surgical Guidance) technology to as many patients as possible. The PediGuard devices, which incorporate the DSG Technology, are the first and only handheld devices capable of alerting surgeons in real time of potential vertebral cortical wall breaches.
Professor Ciaran Bolger, MD PhD and Maurice Bourlion, PhD, co-inventors of the PediGuard with Alain Vanquaethem, are also part of this endeavor.Randal R. Betz, MD, one of the eminent spine surgeons in the US, is one of the early adopters of this technology. He directs SpineGuard’s international clinical study group.Alan Olsen, the founder of Danek Medical Inc., now Medtronic Spine, was elected as SpineGuard’s Chairman of the Board in May 2010.Omnes Capital, IPSA, A Plus Finance and Delta Partners are the four historical financial investors of the company.SpineGuard is a public company listed on Euronext-Growth Paris (ticker: ALSGD) since April 29, 2013.
For more information please visit:http://www.spineguard.com